Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 06 Jul 2026 for TAKEDA PHARMACEUTICAL CO LTD. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John Maraganore: trading record in brief
This profile gathers the share dealings of John Maraganore across 3 companies, led by Alnylam Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc. and Takeda Pharmaceutical Co Ltd. In total, 27 filings cover trades dated from 19 January 2016 to 1 July 2026.
The open-market record consists of 17 sales, with no purchase. The amount is not disclosed for 17 filings. Other entries cover 2 share grants and 7 option exercises.
The latest filing, published on 6 July 2026, reports a share grant in Takeda Pharmaceutical Co Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Maraganore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
3,800 shares0Ordinary SharesSEC:0001395064-26-000275:0
1,585 shares0Common stockSEC:0001439222-22-000049:0
14,167 shares0Common StockSEC:0001735276-21-000095:0
1,036 shares@ US$96.4512.6% of flowCommon StockSEC:0001735276-21-000091:0
33,978 shares@ US$7.1029.9% of flowCommon StockSEC:0001735276-21-000089:0
33,979 shares@ US$7.1029.2% of flowCommon StockSEC:0001735276-21-000083:0
3,415 shares0Common stockSEC:0001439222-21-000054:0
33,979 shares@ US$7.1028.4% of flowCommon StockSEC:0001735276-21-000044:0
15,076 sharesCommon StockSEC:0001553878-16-000036:0
1,838 sharesCommon StockSEC:0001553878-16-000036:1
800 sharesCommon StockSEC:0001553878-16-000036:2
1,281 sharesCommon StockSEC:0001553878-16-000036:3
5,112 sharesCommon StockSEC:0001553878-16-000036:4
3,400 sharesCommon StockSEC:0001553878-16-000036:5
2,245 sharesCommon StockSEC:0001553878-16-000036:6
200 sharesCommon StockSEC:0001553878-16-000036:7
200 sharesCommon StockSEC:0001553878-16-000036:8
15,076 sharesCommon StockSEC:0001553878-16-000036:9
1,200 sharesCommon StockSEC:0001553878-16-000036:10
2,700 sharesCommon StockSEC:0001553878-16-000036:11
4,406 sharesCommon StockSEC:0001553878-16-000036:12
2,114 sharesCommon StockSEC:0001553878-16-000036:13
930 sharesCommon StockSEC:0001553878-16-000036:14
1,136 sharesCommon StockSEC:0001553878-16-000036:15
400 sharesCommon StockSEC:0001553878-16-000036:16
25 of 27 declarations
